ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea

12Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that causes coronavirus disease 2019 (COVID-19) has resulted in a pandemic affecting the most vulnerable in society, triggering a public health crisis and economic collapse around the world. Effective treatments to mitigate this viral infection are needed. Since the eye is a route of virus entrance, we use an in vivo rat model of corneal inflammation as well as human corneal epithelial cells (HCEC) in culture challenged with IFNγ as models of the eye surface to study this issue. We explore ways to block the receptor-binding domain (RBD) of SARS-CoV-2 Spike (S) protein to angiotensin-converting enzyme 2 (ACE2). We found that the lipid mediators, elovanoid (ELV)-N32 or Resolvin D6-isomer (RvD6i) decreased the expression of the ACE2 receptor, furin, and integrins in damaged corneas or IFNγ-stimulated HCEC. There was also a concomitant decrease in the binding of Spike RBD with the lipid treatments. Using RNA-seq analysis, we uncovered that the lipid mediators also attenuated the expression of pro-inflammatoy cytokines participating in hyper-inflammation and senescence programming. Thus, the bioactivity of these lipid mediators will contribute to open therapeutic avenues to counteract virus attachment and entrance to the body.

References Powered by Scopus

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

55178Citations
N/AReaders
Get full text

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

35278Citations
N/AReaders
Get full text

A novel coronavirus from patients with pneumonia in China, 2019

20161Citations
N/AReaders
Get full text

Cited by Powered by Scopus

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition

52Citations
N/AReaders
Get full text

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation

46Citations
N/AReaders
Get full text

Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic

9Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Pham, T. L., He, J., Kakazu, A. H., Calandria, J., Do, K. V., Nshimiyimana, R., … Bazan, N. G. (2021). ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-92293-x

Readers' Seniority

Tooltip

Researcher 8

62%

PhD / Post grad / Masters / Doc 3

23%

Professor / Associate Prof. 1

8%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

56%

Medicine and Dentistry 3

19%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Chemistry 2

13%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 13

Save time finding and organizing research with Mendeley

Sign up for free